NYSE:HIMS Hims & Hers Health (HIMS) Stock Price, News & Analysis $21.31 +0.53 (+2.55%) (As of 09:39 AM ET) Add Compare Share Share Today's Range$20.84▼$21.3450-Day Range$11.25▼$24.7952-Week Range$5.65▼$25.74Volume397,410 shsAverage Volume7.39 million shsMarket Capitalization$4.58 billionP/E RatioN/ADividend YieldN/APrice Target$17.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Hims & Hers Health alerts: Email Address Hims & Hers Health MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.56 Rating ScoreUpside/Downside18.2% Downside$17.00 Price TargetShort InterestHealthy11.28% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.15Based on 7 Articles This WeekInsider TradingSelling Shares$13.89 M Sold Last QuarterProj. Earnings Growth90.00%From $0.20 to $0.38 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.18 out of 5 starsMedical Sector289th out of 879 stocksOffices & Clinics Of Medical Doctors Industry1st out of 7 stocks 2.3 Analyst's Opinion Consensus RatingHims & Hers Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on 9 buy ratings, 7 hold ratings, and no sell ratings.Amount of Analyst CoverageHims & Hers Health has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Hims & Hers Health's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted11.28% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hims & Hers Health has recently decreased by 19.66%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldHims & Hers Health does not currently pay a dividend.Dividend GrowthHims & Hers Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HIMS. Previous Next 2.9 News and Social Media Coverage News SentimentHims & Hers Health has a news sentiment score of 1.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Hims & Hers Health this week, compared to 8 articles on an average week.Search Interest105 people have searched for HIMS on MarketBeat in the last 30 days. This is an increase of 30% compared to the previous 30 days.MarketBeat FollowsOnly 29 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -37% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Hims & Hers Health insiders have sold 611.80% more of their company's stock than they have bought. Specifically, they have bought $1,951,763.00 in company stock and sold $13,892,570.00 in company stock.Percentage Held by Insiders17.71% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Hims & Hers Health's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Hims & Hers Health are expected to grow by 90.00% in the coming year, from $0.20 to $0.38 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hims & Hers Health is -2,078.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hims & Hers Health is -2,078.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHims & Hers Health has a P/B Ratio of 12.91. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Hims & Hers Health's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 Media[Urgent] Hedge Funds Expect Major Crypto MovesIn the year following Bitcoin’s last Halving event, that happened in May of 2020… Bitcoin shot up over 550%. But that’s not all… Click here to register now. About Hims & Hers Health Stock (NYSE:HIMS)Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.Read More HIMS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HIMS Stock News HeadlinesJune 26, 2024 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) CFO Oluyemi Okupe Sells 11,546 SharesJune 25, 2024 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $183,750.00 in StockJuly 8, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.June 25, 2024 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum Sells 45,755 SharesJune 20, 2024 | insidertrades.comIrene Becklund Sells 472 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) StockJune 20, 2024 | marketbeat.comEli Lilly's Stock Surge Driven by GLP-1 DemandShares of Eli Lilly stock are about to hit a new all-time high, sponsored by the pending approval of new weight loss drugsJune 11, 2024 | insidertrades.comInsider Buying: Hims & Hers Health, Inc. (NYSE:HIMS) Director Acquires 110,000 Shares of StockJune 10, 2024 | marketbeat.com3 Sector Stars Lead Growth: Foot Locker, Shake Shack, Hims & HersOne of the market's most closely watched economic reports made a sudden turn last week. The employment situation report (NFP) showed that the U.S. economy is still resiliently adding jobs despite seeing some contradicting indicators placing a ceiling on its growth.July 8, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.June 10, 2024 | marketbeat.com3 Sector Stars Lead Growth: Foot Locker, Shake Shack, Hims & Hers (HIMS)These three stocks are looking to get a chunk of the total added jobs in the economy, meaning that analyst double-digit upside and growth projections are realJune 8, 2024 | marketbeat.comMarketBeat Week in Review – 6/3 - 6/7 (HIMS)Equity markets shrugged off a much hotter-than-expected jobs report, but there could be more volatility after the next readings on inflation come out next weekJuly 2, 2024 | fool.com3 Stocks That Can Double Again in 2024July 2, 2024 | americanbankingnews.comHims & Hers Health, Inc. (NYSE:HIMS) Sees Large Decrease in Short InterestJune 29, 2024 | fool.comIs Hims & Hers Stock a Buy After Short Report?June 29, 2024 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Shares Gap Down to $21.56June 28, 2024 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Given New $23.00 Price Target at Jefferies Financial GroupJune 28, 2024 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Stock Price Down 4.2% Following Insider SellingJune 27, 2024 | fool.comHims & Hers Stock Drops 12.8% After Short ReportSee More Headlines Receive HIMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/06/2024Today7/08/2024Next Earnings (Estimated)8/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Offices & clinics of medical doctors Sub-IndustryN/A Current SymbolNYSE:HIMS CUSIPN/A CIK1773751 Webwww.forhims.com Phone415-851-0195FaxN/AEmployees1,046Year FoundedN/APrice Target and Rating Average Stock Price Target$17.00 High Stock Price Target$26.00 Low Stock Price Target$10.00 Potential Upside/Downside-18.2%Consensus RatingModerate Buy Rating Score (0-4)2.56 Research Coverage16 Analysts Profitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E Ratio103.90 P/E GrowthN/ANet Income$-23,550,000.00 Net Margins-0.24% Pretax Margin0.05% Return on Equity-0.70% Return on Assets-0.55% Debt Debt-to-Equity RatioN/A Current Ratio2.80 Quick Ratio2.48 Sales & Book Value Annual Sales$872 million Price / Sales5.12 Cash FlowN/A Price / Cash FlowN/A Book Value$1.61 per share Price / Book12.91Miscellaneous Outstanding Shares214,790,000Free Float176,747,000Market Cap$4.46 billion OptionableOptionable Beta1.08 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Andrew Dudum (Age 35)Co-Founder, Chairman & CEO Comp: $1.98MMr. Yemi Okupe (Age 38)Chief Financial Officer Comp: $1.01MMs. Melissa Baird (Age 46)Chief Operating Officer Comp: $1.05MMs. Soleil Teubner Boughton (Age 45)Chief Legal Officer & Corporate Secretary Comp: $928.7kDr. Patrick Carroll M.D. (Age 66)Chief Medical Officer, Member of Medical Advisory Board & Director Comp: $54kMr. Mike Chi (Age 44)Chief Commercial Officer Comp: $998kMs. Irene A. Becklund (Age 39)Senior VP, Controller & Principal Accounting Officer Comp: $361.12kMs. Khobi BrooklynChief Communications OfficerMs. Amee ParekhSenior Vice President of Human ResourcesDr. Peter Stahl M.D.Senior VP & Member of Medical Advisory BoardMore ExecutivesKey CompetitorsTeladoc HealthNYSE:TDOCAunaNYSE:AUNALifeMDNASDAQ:LFMDAirSculpt TechnologiesNASDAQ:AIRSSHL TelemedicineNASDAQ:SHLTView All CompetitorsInsiders & InstitutionsDNB Asset Management ASSold 797 shares on 7/5/2024Ownership: 0.008%Oluyemi OkupeSold 11,546 sharesTotal: $256,436.66 ($22.21/share)Michael ChiSold 17,303 sharesTotal: $381,877.21 ($22.07/share)Michael ChiSold 7,500 sharesTotal: $183,750.00 ($24.50/share)Andrew DudumSold 45,755 sharesTotal: $1.05 M ($22.97/share)View All Insider TransactionsView All Institutional Transactions HIMS Stock Analysis - Frequently Asked Questions How have HIMS shares performed this year? Hims & Hers Health's stock was trading at $8.90 at the beginning of the year. Since then, HIMS stock has increased by 133.5% and is now trading at $20.78. View the best growth stocks for 2024 here. How were Hims & Hers Health's earnings last quarter? Hims & Hers Health, Inc. (NYSE:HIMS) posted its quarterly earnings data on Monday, May, 6th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.02 by $0.03. The company's quarterly revenue was up 45.8% on a year-over-year basis. Who are Hims & Hers Health's major shareholders? Top institutional shareholders of Hims & Hers Health include DNB Asset Management AS (0.01%). Insiders that own company stock include Melissa Baird, David B Wells, Alex Bard, Michael Chi, Oluyemi Okupe, Patrick Harrison Carroll, Soleil Boughton, Jules A Maltz, Christopher D Payne, Andrew Dudum, Irene Becklund, Christiane Pendarvis, Lynne Chou O'keefe and Jack Abraham. View institutional ownership trends. How do I buy shares of Hims & Hers Health? Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:HIMS) was last updated on 7/8/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredWhy is NVDA stumbling?July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happ...Porter & Company | SponsoredTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house...Wealthpin Pro | SponsoredNew Government Policy to Wipe Out Seniors WealthDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HIMS Stock Alerts